Clinical Trial Details

Trial ID: L0957
Source ID: IRCT201012275483N1
Associated Drug: Sibutramine
Title: The effect of low calorie diet with and without sibutramine on metabolic syndrome risk factors and sonographic findings in non alcoholic fatty liver
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non alcoholic fatty liver. <br>Diseases of liver;k70, k77;Diseases of liver
Interventions: Intervention 1: Control group: vitamin E 400 IU supplement once daily and weight loss diet for 3 months. Intervention 2: Intervention group: 15-mg capsule of sibutramine once a day half an hour before lunch and vitamin E supplement (400 IU) once a day and
Outcome Measures: Liver echogenicity. Timepoint: before and after intervention. Method of measurement: sonography.;Weight. Timepoint: every two week. Method of measurement: Nestle scale.Total cholestrol. Timepoint: at the beginning and end of the intervation. Method of measurement: enzymatic method with autoanalysis system.;LDL-C. Timepoint: at the beginning and end of the intervation. Method of measurement: enzymatic method with autoanalysis system.;HDL-C. Timepoint: at the beginning and end of the intervation. Method of measurement: enzymatic method with autoanalysis system.;Glucose. Timepoint: at the beginning and end of the intervation. Method of measurement: enzymatic method with autoanalysis system.;AST. Timepoint: at the beginning and end of the intervation. Method of measurement: ELISA.;ALT. Timepoint: at the beginning and end of the intervation. Method of measurement: spectrophotometery.;Ferritin. Timepoint: at the beginning and end of the intervation. Method of measurement: ELISA.;HbA1c. Timepoint: at the beginning and end of the intervation. Method of measurement: ELISA.;Trigliceride. Timepoint: at the beginning and end of the intervation. Method of measurement: enzymatic method with autoanalysis system.
Sponsor/Collaborators: School of health & nutrition, Aras international university
Gender: All
Age: 18 years50 years
Phases: Not applicable
Enrollment: 40
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.
Start Date: 28/01/2011
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/5879